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Background/aim: Brain ischemia and treatment are important topics in neurological science. Free oxygen radicals and inflammation
formed after ischemia are accepted as the most significant causes of damage. Currently there are studies on many chemopreventive agents
to prevent cerebral ischemia damage. Our aim is to research the preventive effect of the active ingredient in syringic acid, previously
unstudied, on oxidative damage in cerebral ischemia.
Materials and methods: The rats were randomly divided into 4 groups: control group (no medication or surgical procedure), sham
group (artery occlusion), artery occlusion + syringic acid group sacrificed at 6 h, and artery occlusion + syringic acid group sacrificed at
24 h. Obtained brain tissue from the right hemisphere was investigated histopathologically and for tissue biochemistry.
Results: Superoxide dismutase and nuclear respiratory factor 1 values decreased after ischemia and they increased after syringic
acid treatment, while increased malondialdehyde levels after ischemia were reduced after treatment. Caspase-3 and caspase-9 values
increased after ischemia and decreased after treatment; this reduction was more pronounced at 24 h.
Conclusion: Our study revealed that syringic acid treatment in cerebral ischemia reduced oxidative stress and neuronal degeneration. In
the light of the biochemical and histopathologic results of the present study, we think that syringic acid treatment may be an alternative
treatment method.
Key words: Brain ischemia, syringic acid, rats, oxidative stress, apoptosis

1. Introduction
Brain ischemia is still a serious clinical problem that
may lead to permanent neurological deficits and serious
complications. Contusion, the initial mechanical damage,
may cause edema and pressure causes brain cell death
and produces permanent damage. If pressure is removed
or continues after the primary injury, the capillary
permeability of the damaged area and surroundings
increases; with the effect of reactive oxygen species (ROS)
and inflammation, more dramatic results may occur due
to secondary damage (1). To prevent ischemia and later
damage, current studies have been and continue to be
conducted on many chemopreventive agents.
Polyphenols, naturally found in many plants, have
antiinflammatory and immunomodulatory effects and
are known to show antioxidant effects, cleaning out ROS
formed by cellular damage and oxidative stress. Simonyi
* Correspondence: drmustafaguven@comu.edu.tr

et al. (2) showed the neuroprotective effect of polyphenols
on cerebral ischemic lesions. Studies on a polyphenolic
derivative of benzoic acid (2,3), syringic acid (SA), have
shown it to have chemoprotective (4) and antimicrobial
(5) activity. In addition, Morton et al. (6) showed that
SA was a strong inhibitor of low-density lipoprotein
oxidation, supporting the scavenging of free radicals,
reducing production of malondialdehyde, and thus
slowing atherosclerosis.
There are no studies on the effects of SA on brain
ischemia found in the literature. The aim of this study was
to investigate the preventive effect of the active ingredient
in SA, a member of the polyphenol group with known
antioxidant properties, on injury due to brain ischemia. SA
may provide a novel and promising therapeutic strategy
for treatment of human cerebral ischemia via antioxidants
and antiapoptotic effects.
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2. Materials and methods
2.1. Experimental animals and study groups
This study used 32 male Sprague Dawley rats weighing 270–
320 g. All animals were fed ad libitum with 7–8 mm pellet
rat food (Bil-Yem Ltd., Turkey) and tap water. To provide
a 12 h darkness, 12 h light environment, photoperiodic
white fluorescent light was used and the temperature and
humidity were held at 21 ± 2 °C and 55%–60%, respectively.
The methods used for animal experiments were in
accordance with the National Institute of Health Guide
for the Care and Use of Laboratory Animals protocols.
Permission was granted by the Çanakkale Onsekiz Mart
University Animal Experiments Local Ethics Committee
(No: 2012/08-16). The rats were randomly divided into
4 groups of 8. Group 1 was the control group (n = 8, no
medication or surgical procedure), Group 2 was the sham
group (n = 8, intraperitoneal single dose of 1 mL of 10%
ethanol and middle cerebral artery occlusion (MCAO),
sacrificed at 24 h), Group 3 was the MCAO + SA group
sacrificed at 6 h (n = 8, 10 mg/kg SA intraperitoneally),
and Group 4 was MCAO + SA group sacrificed at 24 h (n
= 8, 10 mg/kg SA intraperitoneally). Before the rats were
sacrificed, a craniotomy was performed and the complete
brain was obtained, and then they were sacrificed. At the
end of the experiment all animals were deeply anesthetized
with ketamine (50–60 mg/kg) and decapitated.
Brain tissue was investigated histopathologically and
immunohistochemically.
2.2. Surgical procedure
All groups were anesthetized with 5 mg/kg xylazine (Bayer,
Turkey) and 50 mg/kg ketamine hydrochloride (Parke
Davis, Turkey) with spontaneous respiration and at room
temperature. The rats were incised under sterile conditions
on the operating table in the supine position with a right
paramedian skin and subdermis incision in the neck. Using
the previously described intraluminal filament technique,
MCAO with focal cerebral ischemia was induced (7). To
induce MCAO, a 4/0 nylon monofilament suture material
(Ethilon Inc., USA) was advanced intraluminally through
a small incision in the internal carotid artery until 18
mm distal to the right carotid bifurcation. Five minutes
after MCAO was induced, the rats were given 10 mg/kg
SA intraperitoneally (Groups 3 and 4; SA was obtained
from Sigma-Aldrich’s Turkish distributor, İnterlab).
Neurological examinations at hours 6 and 24 were
completed using a scoring system described by Bederson
and modified by Kawamura (8). At the end of hour 6 Group
3 and at the end of hour 24 Groups 1, 2, and 4 were given a
high dose of anesthetic material (ketamine, 50 mg/kg) and
sacrificed. Immediately before sacrifice, the brains of the
rats were obtained by craniotomy. The tissue was stored
in 4% paraformaldehyde solution as previously described
(9). The right hemisphere with MCAO was sent to the
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laboratory for histopathological examination and tissue
biochemical investigation (malondialdehyde (MDA),
superoxide dismutase (SOD), and nuclear respiratory
factor 1 (NRF1)).
2.3. Tissue MDA levels
MDA levels were analyzed for lipid peroxidation products
and results were expressed as MDA nmol/g tissue (10).
MDA levels were obtained using the ELISA method.
2.4. Tissue SOD activity
Tissue SOD activity was measured with a modified
spectrophotometric method at 560 nm as described by
Sun et al. (11). SOD activity was reported as U/mg protein.
2.5. NRF1 assays
NRF1 activates the expression of some key genes
regulating cell growth and nuclear genes necessary for both
mitochondrial DNA transcription and replication as well
as heme biosynthesis and respiration. NRF1 controls the
apoptosis, proliferation, migration, cellular distribution,
and adhesion of target genes. NRF1 levels were measured
with the ELISA method (12,13). Results are reported as ng
mL–1 mg protein–1.
2.6. Histopathological investigation
The brains were labeled and left in 10% neutral
formaldehyde solution. After 24 h in fixative, they were
washed for 6–8 h in running water and rinsed with
an ethanol–xylene series for automatic tissue tracking
(Citadel 2000, Thermo Fisher Scientific Shandon, UK),
and they were submerged in liquid paraffin. Sections 4–6
µm in thickness were cut for routine hematoxylin and
eosin and Luxol fast blue staining, and sections 3–4 µm
in thickness were cut for immunohistochemical staining.
At appropriate places under light microscope at different
magnifications, they were examined and photographed.
Sections made for immunohistochemical staining were left
in xylene for 20 min after rinsing with alcohol (70%–99%),
and were then left in 3% H2O2 solution for 10 min. After
washing with PBS they were heated 4 times at 700–800 W
for 5–10 min in citrate buffer solution and left in secondary
blocking material for 20 min. Different primary antibody
dilutions (1/200–1/250) of every preparation (anticaspase-3
antibody (ab4051) and anticaspase-9 antibody [E23]
(ab32539), Abcam plc, UK) were left for 60–75 min.
Chromogeneous diaminobenzidine solution was used for
contrast staining and Mayer’s hematoxylin stain was also
used. PBS was used for negative controls. The preparations
were covered with an appropriate capping material and
photographed. Results of immunohistochemical staining
tissues were evaluated as % area of immunopositive
reaction in 4 different categories: mild (+), moderate (++),
severe (+++), and very severe (++++). Preparations with
hematoxylin stain were examined in 15 different areas.
Each area was 1200 µm, with remaining neuronal cells in
the area counted to determine cell density.
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2.7. Statistical evaluation
SPSS 19.0 (SPSS Inc., USA) was used for statistical
analysis. Statistical analysis data are expressed as mean
± SD. The comparisons among pre- and postoperation
or drugs were made by using paired t-tests; comparisons
between 2 groups were made with unpaired t-tests. The
comparisons among the 4 groups were made using oneway analysis of variance followed by Bonferroni posttests.
Histopathological findings were evaluated with the
Kruskal–Wallis test as they were nonparametric. Statistical
significance was accepted as P < 0.05.

identified. Only in the sham ischemia group given alcohol
were focal ischemia lesions observed in both hemispheres,
though more so on the right side (Figure 1).
Hematoxylin and eosin staining in the sham ischemia
group showed that neuronal death was increased,
acidophilic neuronal cytoplasm in cells was reduced in
size and had pyknotic shape, and severe vacuolization
had developed. Histomorphometric red neurons were
observed to appear as karyorrhexis-damaged neurons
moving from the cortex regions towards the center
(Figure 1).
In the SA (6 h) group, while a negligible increase in red
neuron cell counts was observed compared to the control
group, there was a significant reduction compared to the
sham ischemia group.
Cells in the sham ischemia group stained with Luxol
fast blue showed slightly darker blue color for pyramidal
neurons compared to the control group and severe
vacuolization and edema formed around both granular
and pyramidal neurons (Figure 2).
In the SA (24 h) group, red neuron cell counts were
higher than in the control group. While the cellular
degeneration was most severe in the sham ischemia group,
it was reduced in the SA groups; however, it was not fully
resolved (Table 2).
Immunoperoxide staining showed edema and
microglial cell clusters around damaged areas in brain
tissue in the ischemia groups. Although edema was
observed in various regions of the hippocampus, it was
more often present surrounding granular cells. In areas
near the hippocampus, the observed microglial cells and
lymphocyte infiltration were at minimal levels.
Caspase-3 immunoactivity was increased, especially in
the cortex and external granular layers. Immunoreactivity
was observed to be greater in situations with alcohol
and long-term ischemia. In the ischemic region, dense
groupings of apoptotic cells were identified (Figure 3;
Table 3).

3. Results
The means and standard deviations of SOD, MDA, and
NRF1 values in the groups are given in Table 1.
Comparing the control group to the other groups,
the SOD values were reduced, and this was found to be
statistically significant (P < 0.05). There was a statistically
significant difference between the ischemia group and
all other groups (P < 0.05), with no significant difference
observed between the 6 and 24 h groups (P > 0.05).
Comparing MDA values between the control group
and other groups, the MDA values increased, and this was
observed to be statistically significant (P < 0.05). In the
ischemia group there was a significant difference between
the other groups (P < 0.05), and only in the 6 and 24 h
groups was the difference not significant (P > 0.05).
NRF1 values were reduced in the other groups
compared to the control group and this was statistically
significant (P < 0.05). There was a significant difference
between the ischemia group and all other groups (P <
0.05). Only in the 6 and 24 h groups was this difference
not significant (P > 0.05).
In the control group, no cellular structure or tissue
injury was observed in brain tissue examined with
immunohistochemical and hematoxylin and eosin
staining for histopathology; neurons and neuroglia with
normal morphology and histological appearance were

Table 1. The activity of superoxide dismutase (SOD) and levels of malondialdehyde (MDA) and nuclear
respiratory factor-1 (NRF1).
SOD

MDA

NRF1

(U/mg protein)

(nmol mL–1 mg protein–1)

(nmol mL–1 mg protein–1)

Group 1

7.2 ± 0.88

0.3 ± 0.12

2.8 ± 0.67

Group 2

1.8 ± 0.33

2.1 ± 0.29

0.3 ± 0.11a

Group 3

4.2 ± 0.97b,d

1.1 ± 0.34b,d

1.3 ± 0.19b,d

Group 4

3.7 ± 0.90c,e

1.2 ± 0.40c,e

1.2 ± 0.24c,e

Groups

a

a

Data are expressed as mean ± SD. Significant difference between groups was analyzed by one-way ANOVA,
where: a, b, c, P < 0.05 compared to Group 1 (control group); d, e, P < 0.05 compared to Group 2 (sham group).
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Figure 1. Representative photomicrographs showing neurons, astrocytes, and microglial
cells stained with hematoxylin and eosin in the ischemic brain area of rats after 6 h and
24 h of MCA occlusion. A) Control group, B) MCAO group, C) MCAO + SA (10 mg/
kg body wt., i.p.) group, sacrificed after 6 h; D) MCAO + SA (10 mg/kg body wt., i.p.)
group, sacrificed after 24 h. Red neurons are shown with stars. Vascular dilatation (d)
and vacuolization (v) are shown. Scale bars = 20 µm.

Figure 2. Representative photomicrographs showing neurons, astrocytes, and microglial
cells stained with Luxol fast blue in the ischemic brain area of rats after 6 h and 24 h
MCA occlusion. A) Control group; B) MCAO group; C) MCAO + SA (10 mg/kg body
wt., i.p.) group, sacrificed after 6 h; D) MCAO + SA (10 mg/kg body wt., i.p.) group,
sacrificed after 24 h. Red neurons are shown with stars. Vascular dilatation (d) is shown.
Scale bars = 20 µm.

236

GÜVEN et al. / Turk J Med Sci
Table 2. Histopathological findings for all groups. Neuronal cells in the area were counted to determine cell density.
Groups

Red neuron

Vacuolization

Cellular degeneration

Edema

Group 1

1.0 ± 0.46

1.0 ± 0.00

1.0 ± 0.00

0.0 ± 0.46

Group 2

4.0 ± 0.76

3.0 ± 0.53

3.0 ± 0.00

3.0 ± 0.64a

Group 3

2.0 ± 0.64b,d

2.0 ± 0.35b,d

1.0 ± 0.00b,d

1.0 ± 0.74b,d

Group 4

3.0 ± 0.00c,e,f

2.0 ± 0.53c,e

2.0 ± 0.00c,e,f

1.0 ± 0.74c,e

a

a

a

Data are expressed as median ± SD. Significant difference between groups was analyzed by Kruskal–Wallis test,
where: a, b, c, P < 0.05 compared to Group 1 (control group); d, e, P < 0.05 compared to Group 2 (sham group); f, P < 0.05
compared to Group 3 (ischemia-SA (6 h) group).

Figure 3. Effects of SA on caspase-3 expression in the ischemic brain site by
immunohistochemical methods at 6 h and 24 h after experimental stroke. Representative
examples of caspase-3 immunohistochemical images in ischemic brain sections
are shown in the control group (A), sham-operated (vehicle) group (B), MCAO +
SA (6 h) group (10 mg/kg, i.p.) (C), and MCAO + SA (24 h) group (10 mg/kg, i.p.)
(D). Caspase-3 expression in neurons (black arrows) is shown. Vacuolization (v) and
neuronal degeneration (dn) are also shown. Scale bars = 20 µm.

Staining of brain tissue with immunoperoxidase
showed reduction in the caspase-3 positivity toward white
matter. Along the zone, different cells were observed to
have different rates of immune reactivity. Along the cortex
and subcortex, glial cells were identified to have strong
caspase-3-positive immunoreactivity. In the hippocampus
CA1 region, caspase-3 immunoreactivity was observed to
be greater in the cytoplasm of granular cells (Figure 3).
In the group administered alcohol after cerebral
ischemia, neuronal degeneration was determined with
severe caspase-9 positivity. In the 6 h ischemia group,

the immunopositivity for caspase-9 was slightly greater
than in the 24 h group. In the large ventricular zone
surrounding cortical neurons, caspase-9 staining showed
immunopositivity in the shape of rings (Figure 4; Table 3).
Neurons in the external granular layer and pyramidal
cell layers were observed to have varying rates of
immunopositivity. The most sensitive area for ischemia
was the CA1 region, with the CA3 and dentate gyrus
regions identified to have cell structures and morphology
more resistant to apoptosis. In the CA1 and CA2 regions
of the hippocampus, cells showed high immunoreactivity
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Table 3. Anticaspase-3 and anticaspase-9 immunoperoxidase staining results for
all groups.
Groups

Anticaspase-3

Group 1

1.0 ± 0.35

1.0 ± 0.46

Group 2

4.0 ± 0.53 a

4.0 ± 0.74 a

Group 3

2.0 ± 0.46 b,d

3.0 ± 0.74 b,d

Group 4

1.0 ± 0.46

2.0 ± 0.88 c,e

c,e,f

Anticaspase-9

Data are expressed as median ± SD. Significant difference between groups was
analyzed by the Kruskal–Wallis test, where: a, b, c, P < 0.05 compared to Group 1
(control group); d, e, P < 0.05 compared to Group 2 (sham group); f, P < 0.05 compared
to Group 3 (ischemia-SA (6 h) group).

Figure 4. Effects of SA on caspase-9 expression in the ischemic brain site by
immunohistochemical methods at 6 h and 24 h after experimental stroke. Representative
examples of caspase-9 immunohistochemical images (black arrows) in ischemic brain
sections are shown in the control group (A), sham-operated (vehicle) group (B), MCAO
+ SA (6 h) group (10 mg/kg, i.p.) (C), and MCAO + SA (24 h) group (10 mg/kg, i.p.)
(D). Caspase-9 expression in neurons (black arrows) is shown. Vacuolization (v) and
dilatation (d) are shown. Scale bars = 20 µm.

to caspase-9, while in the CA3–CA4 region and the
dentate gyrus area the cells were observed to have mild
immunopositivity.
4. Discussion
To reduce neuronal damage caused by cerebral ischemia,
experimental studies of many possible protective agents
have been completed. In our study, a polyphenol that can
be obtained naturally from plants, SA, was used. In the
induced cerebral ischemia model in rats, SA was shown
histopathologically to have a protective effect on the
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ischemic brain area. In addition, after treatment MDA
was decreased and SOD and NRF1 values increased in
biochemical tests, showing a reduction in the formation of
oxidative stress after ischemia.
In spite of developments in treatment of acute strokes,
deaths due to stroke are still the third highest cause of
death in many countries. In addition, strokes are first in
terms of morbidity and cause large economic losses. As a
result, the timely and successful treatment of strokes is very
important. If the blood flow in the brain reduces by more
than 20%, the ATP in brain tissue is quickly consumed
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and anoxic depolarization waves form. As a result of this,
the amount of calcium within cells increases. Increased
calcium may cause activation of catabolic enzymes such
as protease, kinase, endonuclease, and phospholipase. The
increasing calcium within the cells may also cause edema
and functional disruption in mitochondria, destroying
the energy source of the cell. Free oxygen radicals formed
during the ischemic process, along with nitric oxide and
peroxynitrite, trigger apoptotic and necrotic cell death
through a variety of pathways (14,15).
Excessive free oxygen radicals formed during the
ischemic process react with polyunsaturated fat acids and
cause lipid peroxidation (16). MDA is the end product
of lipid peroxidation and at the same time is accepted as
one of the most sensitive markers of lipid peroxidation
(17–19). In a study by Karaoğlan et al. (20), temporary
forebrain ischemia caused an 80% increase in tissue MDA
levels; they found that this increase reduced by 43% with
treatment with tirofiban, a glycoprotein receptor blocker.
Cirak et al. (21) showed that after head trauma, the tissue
MDA levels in rat brains increased in the first 2 h; as time
passed it reduced and the use of melatonin reduced serum
MDA levels. In our study of rats with induced cerebral
ischemia, MDA values were reduced after SA treatment.
There was no significant difference between values 6 and
24 h after ischemia.
SOD, an endogenous mitochondrial antioxidant
enzyme, is a free radical scavenger that turns superoxide
radicals created by cerebral ischemia into less reactive
hydrogen peroxide forms. In increased oxidative stress
situations, SOD is neutralized by H2O2 and other radicals
and thus levels are reduced. In an experimental model
in rats, Islekel et al. (22) showed that SOD activity was
clearly reduced after cerebral ischemia. Both Deng et al.
(23) and Karaoğlan et al. (20) reported that tissue SOD
activity fell after cerebral ischemia, while after treatments
such as 3,6-dimethamidodibenzopyriodonium gluconate
and tirofiban tissue, SOD activity rose again. Kumar et
al. (24) showed that decreasing SOD activity increased
markedly after SA treatment in hypertensive rats. The
main mechanism of the 50 mg/kg dose of SA treatment
was associated with antioxidant effect in this study. In our
study, after SA treatment the rise in SOD values indicated
a reduction in oxidative stress. This supports the view that
SA has antioxidant properties.
Mitochondria are important regulators of the
metabolic activity of cells while also enabling production
and breakdown of free radicals. Mitochondrial biogenesis
is activated in response to cellular stress or environmental
stimuli by many different signals. NRF1 and NRF2 are
mitochondrial transcription factors that activate the
majority of genes coding subunits of the respiratory
complex. Kumari et al. (25) induced cerebral ischemia/

reperfusion in normal and hyperglycemic rats and showed
that after the reperfusion period NRF1 levels increased.
In our study, which simulated an embolism in the human
brain, the intraluminal filament was not retracted to allow
reperfusion. NRF1 values, a marker for mitochondrial
biogenesis, were reduced in the MCAO group. In the
ischemic groups with SA treatment, a significant increase
was observed. In accordance with our study, in the
literature the increase in NRF1 values in the ischemia/
reperfusion groups was in proportion with the reperfusion
time and was shown to increase further with the use of
neuroprotective agents (12,13,25,26) (Table 1).
In ischemic stroke, apoptosis may begin by 2 paths:
intrinsic or extrinsic. Cytochrome c and caspase-3
stimulation triggered by mitochondria forms the intrinsic
pathway (27). Caspase-3 and caspase-9 are known to be
important in apoptosis caused by ischemia of neuronal
cells. Studies of apoptotic neuronal cells found that
caspase-3 may be activated by both intrinsic and extrinsic
signal pathways and as a result supported the idea that
caspase-3 plays a key role in ischemic stroke apoptosis
(28). Activated caspase-3 causes breakdown of DNA (29).
Some studies have shown a relationship between DNA
breakdown and development of ischemic infarction (30).
Li et al. (31), in a temporary focal cerebral ischemia model
in rats, showed that caspase-3 and caspase-9 activity clearly
increased compared to the control group, but this was not
statistically significant. In our study, in the brain tissue
along the cortex and subcortex, glial cells were identified
to have positive immunoreactivity for caspase-3, while in
the hippocampus CA1 region it was more pronounced in
the cytoplasm of granular cells. Neuronal degeneration
after cerebral ischemia was determined by severe caspase-9
positivity. Especially in the 6 h group after ischemia,
caspase-9 immunopositivity was observed to be slightly
greater than in the 24 h group (Figures 3 and 4).
Kim et al. (32) used 2 different doses of caffeic acid–
SA treatment at 10 and 20 mg/kg in experimental cerebral
ischemia. They observed moderate neuroprotective
effects with 10 mg/kg and strong neuroprotective effects
with 20 mg/kg in the hippocampus CA1 region. In the
present study, it was shown that 10 mg/kg SA treatment
had a neuroprotective effect both biochemically and
pathologically, despite induced permanent cerebral
ischemia.
In conclusion, data from our study support the view
that in cerebral ischemia, SA treatment reduces neuronal
degeneration as a result of oxidative stress and may be an
alternative treatment. More comprehensive studies are
definitely required.
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